New injection treatment for seasonal allergic rhinitis in teenagers
Treatments studied
Part of Ear, nose & throat, Immune system & allergy, Lungs & breathing clinical trials.
This study tests a new injectable medication called stapokibart to help teenagers with seasonal allergic rhinitis (hay fever). The goal is to see if this treatment reduces allergy symptoms like sneezing, congestion, and itchy eyes during allergy season.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 12 and 18 years old and weigh at least 40 kg (about 88 pounds)
- You have been diagnosed with seasonal allergic rhinitis (hay fever) for at least 2 years
- You may or may not have itchy, watery eyes from allergies
- You have stopped taking other allergy medications for a certain period before starting the study
- You do not have other serious health conditions that are hard to control
- Your doctor believes it is safe for you to participate
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new biologic medicine (injection) to see if it can better control seasonal allergy symptoms in teens who haven't had good relief from standard treatments like nasal sprays.
This trial tests whether PL-14, a new nasal spray, works better than saline spray at relieving seasonal allergy symptoms like sneezing, itching, and congestion. If it works well and is safe, it could offer patients a new way to manage allergies during pollen season.
This study tests a new nasal spray (ALDP001) in adults with seasonal allergies to ragweed. It aims to find the best dose and how often to use it.
This study tests a new injection called Stapokibart for people with seasonal allergic rhinitis (hay fever triggered by pollen or mold). The goal is to see if it helps control symptoms like sneezing, runny nose, and itchy eyes.
Stapokibart is a new injection that works on a key pathway involved in allergy symptoms. This study will test if this once-every-two-week shot can help reduce runny nose, sneezing, and itchy eyes in people with allergic rhinitis (hay fever).
This study tests a new injection medicine called Stapokibart for treating atopic dermatitis (a chronic skin condition causing itching and inflammation). Your doctor has already decided this medicine might help you before you joined the study.
Hear when a new Seasonal Allergic Rhinitis (SAR) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.